Nurix Therapeutics Inc (NRIX) — Cash Flow Quality Index
Latest as of May 2020:
-1.90x
Nurix Therapeutics Inc (NRIX) has a Cash Flow Quality Index of -1.90x as of May 2020. Operating cash flow of $-14.43 Million is below net income of $7.58 Million, suggesting accrual-heavy earnings not yet converted to cash. Explore Nurix Therapeutics Inc (NRIX) long-term investment share to see how much of total assets are deployed in long-term investments.
Cash Flow Quality Index
-1.90x
Operating CF / Net Income
Operating Cash Flow
$-14.43 Million
USD
Net Income
$7.58 Million
USD
Data as of
May 2020
Most recent filing
Annual Cash Flow Quality Index for Nurix Therapeutics Inc (None–None)
Year-by-year earnings quality comparison for Nurix Therapeutics Inc. For live market cap and the full company financial profile, see NRIX company net worth.
| Year | Quality Index | Operating CF (USD) | Net Income | YoY Change |
|---|
Cash Flow Quality Index = Operating Cash Flow / Net Income. Ratios above 1.0x indicate cash-backed earnings.